Channels - Oncolytic virotherapy in upper gastrointestinal tract cancers :: FRELIP Discovery

Similar Items: Oncolytic virotherapy in upper gastrointestinal tract cancers

Quick Look
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Quick Look
Editorial announcing PubMed indexing of Oncolytic Virotherapy
Quick Look
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
Quick Look
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
Quick Look
Acute Upper Gastrointestinal Bleeding is Associated With Poor Prognosis in Patients With Biliary Tract Cancer
Quick Look
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Quick Look
Three-dimensional tumor cell cultures employed in virotherapy research
Quick Look
Development and applications of oncolytic Maraba virus vaccines
Quick Look
Potential of oncolytic viruses in the treatment of multiple myeloma
Quick Look
A cautionary note on the selectivity of oncolytic poxviruses
Quick Look
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Quick Look
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
Quick Look
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
Quick Look
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Quick Look
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Quick Look
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Quick Look
Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes
Quick Look
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Quick Look
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Quick Look
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Quick Look
Comprehensive Genomic Profiles of Patients With Biliary Tract Cancer
Quick Look
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
Quick Look
The albumin–bilirubin score predicts outcomes in advanced biliary tract cancer treated with durvalumab immunochemotherapy
Quick Look
Clinical impact of trace elements as potential biomarkers for diagnosis and prediction of response to systemic treatment in gastrointestinal cancers